Avoiding Bias in Precision Medicine
Precision medicine, or the tailoring of healthcare towards either a select group or individual based on their needs and physiology instead of their illness, is a well-known and highly-anticipated aspect of healthcare pharmaceuticals, with thousands of articles written on it. ...
5 years agoAvoiding Bias in Precision Medicine
Precision medicine, or the tailoring of healthcare towards either a select group or individual based on their needs and physiology instead of their illness, is a well-known and highly-anticipated aspect of healthcare pharmaceuticals, with thousands of articles written on it. ...
5 years ago
Proventa’s Weekly Round-up – 10/1/19
Happy new year! It’s a fairly slow week as the sector takes stock and begins to get back, with annual price rises the main event in the news - big pharma has announced its regular price increases for the new...
5 years agoProventa’s Weekly Round-up – 10/1/19
Happy new year! It’s a fairly slow week as the sector takes stock and begins to get back, with annual price rises the main event in the news - big pharma has announced its regular price increases for the new...
5 years ago
The Future of Organ-on-a-Chip
Dozens of solutions have been suggested to lessen the crisis that has been hitting pharma R&D recently. Over the last decade, the cost of creating drugs has skyrocketed even as the amount of new medicines reaching market is steadily declining....
5 years agoThe Future of Organ-on-a-Chip
Dozens of solutions have been suggested to lessen the crisis that has been hitting pharma R&D recently. Over the last decade, the cost of creating drugs has skyrocketed even as the amount of new medicines reaching market is steadily declining....
5 years ago
AI and Pharmacovigilance ADR processing
Many of the problems that have long been inherent in Pharmacovigilance (PV) - such as historic limitations in the information that is published in case reports, analysis of electronic health records and integration - have found an answer in the...
5 years agoAI and Pharmacovigilance ADR processing
Many of the problems that have long been inherent in Pharmacovigilance (PV) - such as historic limitations in the information that is published in case reports, analysis of electronic health records and integration - have found an answer in the...
5 years ago
The Abbvie-Allergan Deal: A Matter of Distrust?
Compared to the merger announcement itself, the industry reaction to the $63 billion Abbvie buyout of Allergan, announced this June, was no big surprise. Abbvie, seeking to replace its now-ageing blockbuster drug Humira, was the only suitor for the Botox...
5 years agoThe Abbvie-Allergan Deal: A Matter of Distrust?
Compared to the merger announcement itself, the industry reaction to the $63 billion Abbvie buyout of Allergan, announced this June, was no big surprise. Abbvie, seeking to replace its now-ageing blockbuster drug Humira, was the only suitor for the Botox...
5 years ago